Multiple SclerosisTherapeutics 2014
-
Upload
monique-canonico -
Category
Health & Medicine
-
view
123 -
download
2
description
Transcript of Multiple SclerosisTherapeutics 2014
![Page 1: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/1.jpg)
Monique Canonico DO
Assistant Clinical Professor
John A. Burns School of Medicine
August 20, 2014
MS: UPDATE ON THERAPEUTICS
![Page 2: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/2.jpg)
![Page 3: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/3.jpg)
![Page 4: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/4.jpg)
![Page 5: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/5.jpg)
![Page 6: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/6.jpg)
![Page 7: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/7.jpg)
![Page 8: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/8.jpg)
![Page 9: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/9.jpg)
![Page 10: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/10.jpg)
![Page 11: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/11.jpg)
![Page 12: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/12.jpg)
![Page 13: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/13.jpg)
![Page 14: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/14.jpg)
![Page 15: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/15.jpg)
![Page 16: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/16.jpg)
![Page 17: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/17.jpg)
![Page 18: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/18.jpg)
![Page 19: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/19.jpg)
![Page 20: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/20.jpg)
![Page 21: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/21.jpg)
![Page 22: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/22.jpg)
![Page 23: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/23.jpg)
![Page 24: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/24.jpg)
![Page 25: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/25.jpg)
![Page 26: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/26.jpg)
![Page 27: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/27.jpg)
![Page 28: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/28.jpg)
![Page 29: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/29.jpg)
![Page 30: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/30.jpg)
![Page 31: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/31.jpg)
![Page 32: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/32.jpg)
HIGH DOSE PREDNISONE-ORAL
• For exacerbations
![Page 33: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/33.jpg)
HOW DOES AVONEX WORK AGAIN??
• Manufactured from naturally occurring proteins (endogenous)
• These proteins are manufactured when the body encounters say, a virus
• Controls the immune system
• Therefore helps to decrease exacerbations of MS
![Page 34: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/34.jpg)
PLEGRIDY: WHAT’S THE SCOOP !
• Basically twice a month Avonex
• Pre- filled syringes
• must titrate up
• Subcutaneous not IM
• A polyethylene glycol is attached to the inteferron molecules that allow them to remain in the body for a longer period of time
• Dose is 125 mcg every 2 weeks
![Page 35: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/35.jpg)
SANI SUPP SUPPOSITORY
• For constipation
![Page 36: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/36.jpg)
![Page 37: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/37.jpg)
PLEGRIDY APPROVED AUGUST 2014
![Page 38: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/38.jpg)
PLEGRIDY TITRATION
![Page 39: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/39.jpg)
![Page 40: Multiple SclerosisTherapeutics 2014](https://reader038.fdocuments.us/reader038/viewer/2022110302/5499ba6fb4795927538b4be9/html5/thumbnails/40.jpg)